Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Myeloid 3Breast 2Other neoplasm 1Other hematologic neoplasm 1NET 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Breast Neoplasms 3092Triple Negative Breast Neoplasms 504Ovarian Neoplasms 224Colorectal Neoplasms 189Carcinoma, Non-Small-Cell Lung 187Prostatic Neoplasms 180Neoplasms 171Lung Neoplasms 164Neoplasm Metastasis 159Melanoma 116Stomach Neoplasms 113Pancreatic Neoplasms 111Endometrial Neoplasms 105Uterine Cervical Neoplasms 93Squamous Cell Carcinoma of Head and Neck 87Head and Neck Neoplasms 81Colonic Neoplasms 81Carcinoma, Intraductal, Noninfiltrating 80Sarcoma 63Breast Carcinoma In Situ 61Carcinoma, Renal Cell 60Urinary Bladder Neoplasms 59Esophageal Neoplasms 58Motor Activity 57Brain Neoplasms 50Lymphedema 42Breast Cancer Female 40Advanced Breast Cancer 40Liver Neoplasms 39Gastrointestinal Neoplasms 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hypersensitivity × Breast × 1 year × Clear all
NCT07572162 2026-05-07

Post-market Safety Study of LUMISIGHT

Lumicell, Inc.

Not yet recruiting
1,500 enrolled
Breast

Anaphylaxis, Breast Neoplasms, Drug Hypersensitivity, Hypersensitivity

NCT07478315 2026-03-17

IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life

Charles LeMoyne Hospital

Phase NA Not yet recruiting
50 enrolled
Breast

Breast Neoplasms, Hypersensitivity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡